Christine Lind
Chief Executive Officer at BACTIGUARD HOLDING AB
Net worth: 19 675 $ as of 2024-04-29
Christine Lind active positions
| Companies | Position | Start | End |
|---|---|---|---|
| XSPRAY PHARMA AB | Director/Board Member | 2018-12-31 | - |
| Independent Dir/Board Member | 2018-12-31 | - | |
| MENDUS AB | Independent Dir/Board Member | 2019-12-31 | - |
| Chairman | 2021-01-21 | - | |
| Director/Board Member | 2019-12-31 | 2021-01-21 | |
| BACTIGUARD HOLDING AB | Chief Executive Officer | 2024-04-11 | - |
Lind Growth Strategy AB
 Lind Growth Strategy AB Miscellaneous Commercial ServicesCommercial Services Lind Growth Strategy AB is a private company that provides life science consulting services. The CEO of the Swedish company is Christine Lind. | Chairman | 2019-02-28 | - |
| Chief Executive Officer | - | - | |
| Director/Board Member | - | - | |
NDA Group AB
 NDA Group AB Miscellaneous Commercial ServicesCommercial Services NDA Group AB provides drug developmental consultancy services to the pharmaceutical industry. It focuses on all phases of development and therapeutic areas such as pre-submission, submission, assessment, post authorization, regulatory, pharmacovigilance, and health technology assessment. The company was founded in 1997 and is headquartered in Upplands Väsby, Sweden. | Corporate Officer/Principal | 2021-03-31 | - |
| Shinka Life Sciences AB | Corporate Officer/Principal | - | - |
Career history of Christine Lind
Former positions of Christine Lind
| Companies | Position | Start | End |
|---|---|---|---|
| MEDIVIR AB | Chief Executive Officer | 2017-03-31 | 2018-10-14 |
| Corporate Officer/Principal | 2015-02-28 | 2017-03-31 | |
| President | - | 2018-10-14 | |
| BIOARCTIC AB | Corporate Officer/Principal | 2018-12-31 | - |
| Medivir Personal AB | Director/Board Member | - | - |
| ░░░░░░░░░ ░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
| ░░░░░░░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
Training of Christine Lind
| Columbia Business School | Masters Business Admin |
| The Leonard N Stern School of Business | Undergraduate Degree |
Statistics
International
| Sweden | 11 |
| United States | 4 |
Operational
| Corporate Officer/Principal | 5 |
| Director/Board Member | 5 |
| Chief Executive Officer | 3 |
Sectoral
| Health Technology | 7 |
| Commercial Services | 3 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 5 |
|---|---|
| MEDIVIR AB | Health Technology |
| BIOARCTIC AB | Health Technology |
| XSPRAY PHARMA AB | Health Technology |
| MENDUS AB | Health Technology |
| BACTIGUARD HOLDING AB | Health Technology |
| Private companies | 6 |
|---|---|
LifeCell Corp.
 LifeCell Corp. BiotechnologyHealth Technology LifeCell Corp. develops and markets tissue repair products. The firm focuses on reconstructive, urogynecologic and orthopedic surgical procedures. Its products include alloderm, strattice, graft jacket, allocraftdbm and repliform. The company was founded in 1986 and is headquartered in Branchburg, NJ. | Health Technology |
NDA Group AB
NDA Group AB Miscellaneous Commercial ServicesCommercial Services NDA Group AB provides drug developmental consultancy services to the pharmaceutical industry. It focuses on all phases of development and therapeutic areas such as pre-submission, submission, assessment, post authorization, regulatory, pharmacovigilance, and health technology assessment. The company was founded in 1997 and is headquartered in Upplands Väsby, Sweden. | Commercial Services |
| Medivir Personal AB | |
| Glycovisc BioTech AB | |
Lind Growth Strategy AB
Lind Growth Strategy AB Miscellaneous Commercial ServicesCommercial Services Lind Growth Strategy AB is a private company that provides life science consulting services. The CEO of the Swedish company is Christine Lind. | Commercial Services |
| Shinka Life Sciences AB |
- Stock Market
- Insiders
- Christine Lind
- Experience